About the PREVAIL Network

The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.
Thumb_Brochure_PREVAIL_725h

Related Resources

Report

mRNA Report

Video

ClinConvos, Episode 5: Sienneh Tamba Discusses the Importance of Regulatory Compliance

Video

ClinConvos, Episode 3: 40+ Years and Still no HIV Vaccine: Has Patience Been a Virtue?

Indication Overview

Our Clinical Trial Experience With Tuberculosis

Indication Overview

Our Clinical Trial Experience With HIV

Indication Overview

Our Clinical Trial Experience With Malaria

Brochure

Our Experience in sub-Saharan Africa

Brochure

Vaccine Development